From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

William Blair cut their Q1 2025 earnings per share (EPS) estimates for Arcturus Therapeutics in a report issued on Thursday, March 13th. William Blair analyst M. Minter now forecasts that the ...

AgyemangFrom Monday, 17th March to Thursday 20th March, 2025, Ghana is hosting a gathering of science, health and ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

Copyright © 2025 Bleacher Report, Inc. A Warner Bros. Discovery Company. All Rights Reserved.

Block's expected EPS growth and forward P/E ratio indicate it is significantly undervalued compared to SPYV's top holdings.

Despite earning a PhD in Physics from Cambridge, this woman struggled for months to find a job. She documented her experience ...

Asana's 2024 results showed mixed performance, with 11% sales growth and positive free cash flow. See why I rate ASAN stock a ...